Medifast Inc (MED) 34.45 $MED Medifast, Inc. Announces

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Medifast Inc (MED) 34.45 $MED

Medifast, Inc. Announces Quarterly Dividend
PR Newswire - Wed Jun 15, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that its Board of Directors has declared a $0.25 cash dividend to its stockholders. The quarterly cash dividend of $0.25 per share is payable on August 10, 2016 to stockholders of record as of the close of business on June 27, 2016.
MED: 34.45 (+0.27)

Medifast, Inc. to Participate in the 17th Annual B. Riley & Co. Investor Conference
PR Newswire - Wed May 11, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today that Timothy Robinson, Chief Financial Officer, will present at the 17th Annual B. Riley & Co. Investor Conference on Wednesday, May 25, 2016 in Hollywood, CA.
MED: 34.45 (+0.27)

5 DuPont-Tested Stocks that Promise Solid Returns
Zacks Equity Research - Zacks Investment Research - Fri May 06, 12:42PM CDT
Taking a step beyond the basic ROE and analyzing it at an advanced level could lead to better returns.
PM: 103.38 (+0.29), TJX: 78.75 (-0.21), MED: 34.45 (+0.27), NVR: 1,820.98 (-9.02)

Medifast posts 1Q profit
Automated Insights - Wed May 04, 4:39PM CDT
OWINGS MILLS, Md. (AP) _ Medifast Inc. (MED) on Wednesday reported first-quarter profit of $4.3 million.
MED: 34.45 (+0.27)

Medifast, Inc. Announces First Quarter 2016 Financial Results
PR Newswire - Wed May 04, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the first quarter ended March 31, 2016.
MED: 34.45 (+0.27)

McCormick Buys Botanical Food Company for $114M Cash
Zacks Equity Research - Zacks Investment Research - Wed Apr 20, 10:42AM CDT
McCormick & Co., Inc. (MKC) recently announced the acquisition of Australia-based Botanical Food Company, Pty Ltd, a privately held firm, for approximately 150 million Australian dollars ($114 million) in cash.
MKC: 105.94 (-1.02), MED: 34.45 (+0.27), SYY: 51.64 (+0.05), CPB: 66.71 (-0.39)

Medifast, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2016
PR Newswire - Thu Apr 14, 3:05PM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, will announce financial results for the first quarter ended March 31, 2016 on Wednesday, May 4, 2016, after market close. The Company will host a conference call to discuss these results with additional comments and details. Participants from the Company will be Michael C. MacDonald, Chairman and Chief Executive Officer, and Timothy Robinson, Chief Financial Officer.
MED: 34.45 (+0.27)

McCormick Withdraws Bid for Premier Foods; Shares Fall
Zacks Equity Research - Zacks Investment Research - Thu Apr 14, 1:50PM CDT
McCormick & Co., Inc. (MKC) recently announced that it has abandoned its plans to acquire UK-based Premier Foods, after completing its due diligence review of the food manufacturer. Shares of McCormick declined 2.2% on Apr 13.
MKC: 105.94 (-1.02), MED: 34.45 (+0.27), SYY: 51.64 (+0.05), CPB: 66.71 (-0.39)

Moving Average Crossover Alert: Medifast (MED)
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 8:24AM CDT
Medifast Inc. (MED) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
MED: 34.45 (+0.27)

Medifast® Sports Nutrition Product Line Announces New Partnerships
PR Newswire - Mon Apr 04, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today three new strategic partnerships for its sports nutrition product line, Dual Fuel(TM). To help launch the product line developed for athletes and active consumers, the company has signed sponsorship agreements with both the Colonial Athletic Association and the Atlantic Hockey Conference, which will distribute Dual Fuel(TM) bars and ready-to-drink shakes to student-athletes and fans onsite at conference tournaments. The company has also hired Play By Play Sports, a powerful sports marketing agency partner, to advance its distribution footprint among college and university programs.
MED: 34.45 (+0.27)

Medifast® Celebrates Nutrition Month with New Cookbook Featuring Flavorful, Nutritionally Balanced Recipes
PR Newswire - Mon Mar 21, 7:00AM CDT
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to celebrate March's Nutrition Month with the launch of a premier Medifast cookbook, Simply Well(TM): An Everyday, Healthy Cookbook ©. It is designed to spice up meals while offering customers healthy choices to keep them feeling full and satisfied.
MED: 34.45 (+0.27)

Why Sunrun, Medifast, and Zumiez Slumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Fri Mar 11, 6:27PM CST
Image: Sunrun. Stocks rallied on Friday, finishing a fourth consecutive week of gains as investors bought into the idea that further government stimulus measures from central banks in Europe and elsewhere in the world might be enough to jump-start...
ZUMZ: 15.62 (+0.32), MED: 34.45 (+0.27)

Medifast, Inc. Announces Fourth Quarter and Full Year 2015 Financial Results
PR Newswire - Thu Mar 10, 3:05PM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and full year ended December 31, 2015.
MED: 34.45 (+0.27)

Medifast® Announces Latest Industry and Community Recognitions for Chairman & Chief Executive Officer Michael MacDonald
PR Newswire - Tue Feb 02, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is proud to announce that its Chairman & CEO Michael MacDonald was appointed to serve as Treasurer of the Direct Selling Association (DSA), a national trade association of the leading firms that manufacture and distribute goods and services sold directly to consumers. A member of the DSA executive committee since 2014, MacDonald is also an active board member of the Direct Selling Education Foundation (DSEF), which offers consumer, education, ethics, and entrepreneurship initiatives that help demonstrate direct selling's important role in supporting communities and strengthening economies.
MED: 34.45 (+0.27)

Nutrisystem (NTRI) Adds 16 Items to Menu, Unveils New Diet
Zacks Equity Research - Zacks Investment Research - Tue Jan 26, 10:50AM CST
Nutrisystem Inc. (NTRI) has added 16 new items to its ready-to-go and fresh-frozen line of products.
MED: 34.45 (+0.27), NTRI: 26.36 (-0.51), WMT: 74.06 (+0.22), WTW: 12.03 (+0.14)

Medifast® Introduces Sports Nutrition Product Line, Partners with The V Foundation for Cancer Research® and Rutgers University® to Launch Dual Fuel(TM)
PR Newswire - Wed Jan 20, 7:00AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, announced today the launch of a sports nutrition product line, which will be marketed through partnerships with Rutgers University® and The V Foundation for Cancer Research®. The V Foundation, one of the nation's leading cancer research funding organizations, was started by famed college basketball coach and revered Rutgers' Alum, Jim Valvano.
MED: 34.45 (+0.27)

Upgrade Alert for Medifast (MED)
Comtex SmarTrend(R) - Tue Jan 12, 8:04AM CST
Medifast (NYSE:MED) was upgraded from Neutral to Buy at Sidoti today. The stock closed yesterday at $29.40 on volume of 179,000 shares, above average daily volume of 106,000. Over the past year, Medifast has traded in a range of $26.14 to $33.86 and closed yesterday at $29.40, 12% above that low. In the last five trading sessions, the 50-day moving average (MA) has remained constant while the 200-day MA has remained constant.
MED: 34.45 (+0.27)

Take Shape For Life® Kicks-Off New Year with Success Stories Featured in People Magazine's Annual Half Their Size Issue
PR Newswire - Mon Jan 11, 7:30AM CST
Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, is excited to announce that three weight loss successes in their Take Shape For Life direct selling division have been featured in the January 11, 2016 People Magazine's Half Their Size issue, available on newsstands now. This year, Take Shape For Life successes Heather Patterson (43), and husband and wife team, Steven (57) and Susan Smelser (55), shared their inspirational stories and credited their weight-loss transformations to Take Shape For Life. In the issue, they highlighted the organization's proven products and programs, their Health Coaches, and community of support which fosters Optimal Health.
MED: 34.45 (+0.27)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading